跳至主要内容
临床试验/ISRCTN14728094
ISRCTN14728094已完成Unknown

Effectiveness of magnesium supplementation (i.e., Magtein®) on anxiety, mood, and sleep quality of adults with poor sleep quality and nonclinical anxiety: a randomized, double-blind, placebo-controlled trial

AIDP0 个研究点目标入组 80 人开始时间: 2024年4月15日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Individuals who reported poor sleep quality, determined by a score of 8-21 on the Insomnia Severity Index (Bastien et al., 2001)
  • 2. Weight between 50-100 kg (i.e., 110-220 lbs)
  • 3. Not meeting any of the exclusion criteria

排除标准

  • 1. A history of sleep-affecting disorders
  • 2. Recent highly stressful events within 2 weeks of baseline
  • 3. Use of sleep supplements or medications
  • 4. Usage of sleep-pattern-influencing medications within 1 month of baseline
  • 5. Use of calcium channel blockers, anxiolytics or SSRIs, no more than 5 times per month, and not within 7 days of baseline
  • 6. Current hormone therapy
  • 7. Unstable use of other medication
  • 8. Excessive alcohol consumption
  • 9. Smoking
  • 10. Elevated caffeine intake
  • 11. Irregular sleep-inducing work schedules
  • 12. Recent travel to different time zones within 1 month of study
  • 13. Pregnancy, attempts at conception, or breastfeeding
  • 14. Refusal to abstain from other magnesium products for 2 weeks before and during the trial
  • 15. Individuals incompatible with the study protocol

研究者

发起方
AIDP

相似试验